Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial.

Ahmed M A SobhNoura H Abd EllahMaryt A HosnyMohamed S AbdellahMohammed K Ali

Published in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2021)

Self-administered vaginal lidocaine in-situ gel 10 min before copper IUD insertion is effective in pain reduction in women with previous caesarean delivery only.

Keyphrases

double blind
chronic pain
placebo controlled
clinical trial
pain management
study protocol
neuropathic pain
open label
phase ii
phase iii
hyaluronic acid
wound healing
spinal cord injury